WeLeader Biomedical Co., Ltd. (TPEX:7713)
Taiwan · Delayed Price · Currency is TWD 67.20
+0.10 (0.15%)
May 29, 2026, 1:30 PM CST
WeLeader Biomedical Market Cap
WeLeader Biomedical has a market cap or net worth of 3.06 billion as of May 29, 2026. Its market cap has increased by 16.26% in one year.
Market Cap
3.06B
Enterprise Value
3.62B
Revenue
1.14B
Ranking
n/a
PE Ratio
14.53
Stock Price
67.20
Market Cap Chart
Since January 2, 2024, WeLeader Biomedical's market cap has decreased from 3.43B to 3.06B, a decrease of -10.91%. That is a compound annual growth rate of -4.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.06B | -8.45% |
| Dec 31, 2025 | 3.34B | 2.93% |
| Dec 31, 2024 | 3.24B | -5.45% |
| Jan 2, 2024 | 3.43B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 6.19B |
| Hi-Clearance | 5.99B |
| Bonraybio | 3.61B |
| Applied BioCode | 2.54B |
| A Plus Biotechnology | 2.47B |
| Wellell | 2.46B |
| Medimaging Integrated Solution | 2.33B |
| OK Biotech | 2.09B |